Public funding of drugs for orphan diseases
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Public funding of drugs for orphan diseases. / Hughes, D.; Hughes, D.A.
2005. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK.
2005. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2005, 'Public funding of drugs for orphan diseases', Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2005). Public funding of drugs for orphan diseases. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK.
CBE
Hughes D, Hughes DA. 2005. Public funding of drugs for orphan diseases. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK.
MLA
Hughes, D. a D.A. Hughes Public funding of drugs for orphan diseases. South West Clinical Pharmacology Group, University of Oxford, UK, 03 Ion 0001, Papur, 2005.
VancouverVancouver
Hughes D, Hughes DA. Public funding of drugs for orphan diseases. 2005. Papur a gyflwynwyd yn South West Clinical Pharmacology Group, University of Oxford, UK.
Author
RIS
TY - CONF
T1 - Public funding of drugs for orphan diseases
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2005/11/1
Y1 - 2005/11/1
M3 - Paper
T2 - South West Clinical Pharmacology Group, University of Oxford, UK
Y2 - 3 January 0001
ER -